Ascensia Diabetes Care Holdings AG is a global leader in diabetes technology and a company focused entirely on helping people with diabetes. The company mission is to empower those living with diabetes through innovative solutions that simplify and improve their lives. It does this by providing high quality solutions and precision tools that help patients manage their diabetes and take charge of their lives.

Ascensia is recognized as a leader in delivering highly accurate, convenient, easy-to-use glucose monitoring systems and testing supplies. Ascensia is home to the world renowned CONTOUR^® portfolio of blood glucose monitoring systems and is the exclusive global distribution partner for the Eversense^® continuous glucose monitoring systems from Senseonics. These products combine advanced technology with user-friendly functionality to help people with diabetes manage their condition and make a positive difference to their lives.

Ascensia has a proud heritage as a leading provider of innovative technologies for diabetes care and continues to build on this longstanding commitment to the diabetes community. For more than 80 years, the company has developed state-of-the-art systems that meet the needs of people with diabetes, and, along the way, has been responsible for introducing many industry firsts. Ascensia was established as a standalone company in 2016 through the sale of Bayer Diabetes Care to PHC Holdings, and its products are sold in more than 110 countries.